|
|
||||||||
The Pulmonary Center, Boston University School of Medicine, Boston, MA 02118
The precursor for IL-16 (pro-IL-16) is a nuclear and cytoplasmic PDZ domain-containing protein. In this study we have found that pro-IL-16 is absent or mutated in four T lymphoblastic leukemia cell lines examined. Ectopic expression of pro-IL-16 in pro-IL-16-negative Jurkat cells blocks cell cycle progression from G0/G1 to S phase associated with elevated levels of the cyclin-dependent kinase inhibitor p27KIP1. Pro-IL-16 decreases p27KIP1 degradation by reducing transcription and subsequent expression of Skp2, a key component of the SCFSkp2 ubiquitin E3 ligase complex. Taken together, these findings identify pro-IL-16 as a novel regulator of Skp2 expression and p27KIP1 levels and implicate a role for pro-IL-16 in T cell proliferation.
This article has been cited by other articles:
![]() |
Y. Zhang, M. Tuzova, Z.-X. J. Xiao, W. W. Cruikshank, and D. M. Center Pro-IL-16 Recruits Histone Deacetylase 3 to the Skp2 Core Promoter through Interaction with Transcription Factor GABP J. Immunol., January 1, 2008; 180(1): 402 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bond, G. B. Sala-Newby, Y.-J. Wu, and A. C. Newby Biphasic effect of p21Cip1 on smooth muscle cell proliferation: Role of PI 3-kinase and Skp2-mediated degradation Cardiovasc Res, January 1, 2006; 69(1): 198 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ren, X. Zhan, G. Martens, J. Lee, D. Center, S. K. Hanson, and H. Kornfeld Pro-IL-16 Regulation in Activated Murine CD4+ Lymphocytes J. Immunol., March 1, 2005; 174(5): 2738 - 2745. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |